Navigation Links
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
Date:3/12/2009

data evaluating the safety and performance of a bioabsorbable drug eluting coronary stent out to two years. Abbott's bioabsorbable everolimus eluting coronary device is made of polylactic acid, a proven biocompatible material that is commonly used in medical implants such as dissolvable sutures. As with a metallic stent, Abbott's bioabsorbable stent is designed to restore blood flow by propping a clogged vessel open, and to provide support until the blood vessel heals. Unlike a metallic stent, however, a bioabsorbable device is designed to be slowly metabolized by the body and completely absorbed over time.

"Abbott has consistently been at the forefront of advances in interventional cardiology - from the early days of angioplasty to our continued success with bare metal stents and the market-leading XIENCE V drug eluting stent. Our bioabsorbable device is another example of scientific innovation leading to an interventional breakthrough," said John M. Capek, Ph.D., executive vice president, Medical Devices, Abbott. "Today's data publication in The Lancet confirms the promise our bioabsorbable device holds as a vasorestorative therapy for patients with coronary artery disease."

Abbott will begin enrolling patients in the second phase of its international ABSORB clinical trial in the first half of 2009.

About the ABSORB Clinical Trial

The ABSORB trial is a prospective, non-randomized (open label), two-phase study designed to enroll approximately 110 patients in Australia, Belgium, Denmark, France, the Netherlands, New Zealand, Poland and Switzerland. Key endpoints of the study include assessments of safety - MACE and stent thrombosis rates - at 30 days, six, nine and 18 months, and one and two years, with additional annual clinical follow-up for up to five years, as well as an assessment of the acute performance of the bioabsorbable drug eluting stent, including successful deployment of the sten
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
4. TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
5. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
6. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
7. Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine
8. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
9. SurgiLance Safety Lancet Part of Major HIV Testing Initiative in Sub-Saharan Africa
10. International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
11. New Data Published in The Lancet Show GSKs ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... TAMPA, Fla. , Sept. 17, 2014   ... announced today that Business Insurance magazine has ... Insurance" distinction for the third year in a row. ... joint effort of Business Insurance  and the Best ... evaluation, is open to all publicly or privately-held insurance ...
(Date:9/17/2014)... , Sept. 17, 2014 Women everywhere know ... are not only uncomfortable, they,re often also embarrassing and ... pH-D Feminine Health Support ( http://ph-defense.com ) is a ... is an all-natural, homeopathic product. Odor, ... symptoms of vaginal infection. In many cases, the cause ...
(Date:9/17/2014)... 2014  NuView Life Sciences, Inc. (NuView) announced ... agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) to ... biomarker to detect cancers of the breast and ... diagnostic-imaging applications. NuView retains all rights for the ... urine screen applications. Under the terms ...
Breaking Medicine Technology:myMatrixx Honored with "Best Places to Work in Insurance" Award 2New Product from Vireo Systems: pH-D Feminine Health Support 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5
... that a new market research report is available ... Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th ... DescriptionThe report provides a detailed understand ... co-promotion and co-marketing deals. The majority of deals ...
... Oct. 7 CryoLife, Inc. (NYSE: CRY ... processing company, today announced that its BioGlue Surgical Adhesive ... Health, Labor and Welfare (MHLW) for use in the ... Medical, Inc. (CMI) will distribute BioGlue in Japan for ...
Cached Medicine Technology:Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 2Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 3Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 4Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 5Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 6Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 7Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 8Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 9CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 2CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 3CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 4CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 5
(Date:9/17/2014)... Dennis Thompson ... News) -- Exposure in the womb to household chemicals ... of developing asthma, Columbia University researchers reported in a ... increased risk of developing asthma between age 5 and ... high levels of two phthalates (pronounced thal-ates), the researchers ...
(Date:9/17/2014)... -- Positive messages about the health benefits of quitting ... new study suggests. Although smokers who think quitting ... the harmful effects of smoking, researchers found smokers who ... from "gain-framed," or positive, messages about how quitting will ... a mix of both types of messages might get ...
(Date:9/17/2014)... adjourns this month for the November elections, one of ... way out the chamber door will be the Sustainable ... Act of 2014. In a new commentary in the ... what he and other advocates saw as the merits ... how Medicare pays doctors will return for the next ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Wright ... Conserve line of metal-on-metal hip replacements continue to ... U.S. District Court, Northern District of Georgia, Bernstein ... List issued by the U.S. Judicial Panel on ... 397 product liability claims have been filed in ...
(Date:9/17/2014)... 17, 2014 Boston Children’s Museum ... a monthly concert series, introducing young Museum visitors ... Top, America’s premier national platform celebrating the stories, ... of the young musicians featured will also be ... Children’s Museum is fortunate to partner with the ...
Breaking Medicine News(10 mins):Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 3Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 4Health News:More Than One Kind of Message May Convince Smokers to Quit, Study Says 2Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3
... step is compromise with House plan, before proposal can become ... gave President Barack Obama a Christmas Eve gift on Thursday ... extend coverage to 31 million uninsured Americans. , Obama said ... that he has sought since his inauguration on Jan. 20. ...
... ... deliver point-of-care drug information on Android devices, , ... Hudson, OH (PRWEB) December 24, 2009 ... healthcare professionals, has released an application for Google Android devices. This latest ...
... ... a distributor of new-to-market nutraceutical and functional food ingredients and ... Purple Stuff, has announced that LuraLean®, AHD’s condensed, water-soluble, dietary ... levels already within the normal range and support regularity, is ...
... , Children,s National Posts Favorite Story on Its Site ... the holiday classic ,Twas the Night before Christmas by ... Center. A video of the classic story being read by ... website, so children and families around the country and world can ...
... , , MINNEAPOLIS, Dec. 23 ... Year,s resolutions for many Minnesotans. As the holiday approaches, ... Minnesota(SM), hopes to motivate them to make a fresh ... most smokers resolve to quit. The new ad acknowledges ...
... , ATLANTA, Dec. 23 At ... of corporate citizenship by fulfilling our mission to offer ... products, unsurpassed quality and service standards, and creative solutions. ... the communities where we do business, we embrace opportunities ...
Cached Medicine News:Health News:Senate Passes Health Reform Package 2Health News:Senate Passes Health Reform Package 3Health News:Senate Passes Health Reform Package 4Health News:Lexi-Comp Now Available for Android™ 2Health News:AHD International & Funktional Beverages, Inc Launch Red Stuff™ with LuraLean 2Health News:'Twas the Night Before Christmas: First Lady Michelle Obama Reads the Holiday Classic 2Health News:Smokers: Resolve to Get the Monkey off Your Back in 2010 2Health News:Smokers: Resolve to Get the Monkey off Your Back in 2010 3Health News:Angelica Extends Helping Hand to Haitian Hospital 2
... line of Surgical Microscope Accessories includes ... lenses, fiber optic cables, and fiberoptic ... Adaptor attaches directly to a Zeiss® ... used to mount the Photo Adaptor ...
Inquire...
... Femoral Compression System consists of a ... FemoStop Femoral Compression System.,Both devices work ... Hemostatic Dressing achieves topical hemostasis by ... while FemoStop Femoral Compression System provides ...
... system. It stores patient chart notes, x-rays, laboratory ... would normally put in a file folder. Your ... write them, file them, find them, determine billing ... lost. They find their way to your house ...
Medicine Products: